FDG-PET in the prediction of survival of patients with cancer of the pancreas: a pilot study (Q36641933)

15 August 2017

FDG-PET in the prediction of survival of patients with cancer of the pancreas: a pilot study (English)

1 reference

15 August 2017

0 references

Maisey NR

1

1 reference

15 August 2017

Webb A

2

1 reference

15 August 2017

Flux GD

3

1 reference

15 August 2017

Padhani A

4

1 reference

15 August 2017

Cunningham DC

5

1 reference

15 August 2017

Ott RJ

6

1 reference

15 August 2017

Norman A

7

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 August 2000

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

83

1 reference

15 August 2017

287-293

1 reference

15 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1054/bjoc.2000.1166

15 August 2017

0 references

cites work

A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374572

Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374572

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374572

Combined modality treatment with accelerated radiotherapy and chemotherapy in patients with locally advanced inoperable carcinoma of the pancreas: results of a feasibility study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374572

Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374572

Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374572

Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374572

Cisplatin and protracted venous infusion 5-fluorouracil (CF)--good symptom relief with low toxicity in advanced pancreatic carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374572

Can positron emission tomography (PET) be used to detect subclinical response to cancer therapy? The EC PET Oncology Concerted Action and the EORTC PET Study Group

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374572

Reporting results of cancer treatment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374572

Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374572

The performance of a multiwire proportional chamber positron camera for clinical use.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374572

Evaluation of intraoperative radiation therapy for unresectable pancreatic cancer with FDG PET.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374572

Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374572

Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374572

18F-fluorodeoxyglucose positron emission tomography and the prognosis of patients with pancreatic adenocarcinoma

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374572

Chemotherapy prolongs survival in inoperable pancreatic carcinoma.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374572

Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro[18F]-D-glucose

20 September 2018

1 reference

12 December 2020

The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma

1 reference

12 December 2020

FDG-PET for the evaluation of tumor viability after anticancer therapy

1 reference

12 December 2020

Non-focal enlargement in pancreatic carcinoma

1 reference

12 December 2020

Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment

1 reference

12 December 2020

Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy

1 reference

12 December 2020

Early treatment response in malignant lymphoma, as determined by planar fluorine-18-fluorodeoxyglucose scintigraphy

1 reference

12 December 2020

F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer

1 reference

12 December 2020

FDG-PET for predicting the prognosis of malignant lymphoma

1 reference

12 December 2020

Value of fluorine-18-fluorodeoxyglucose and thallium-201 in the detection of pancreatic cancer

1 reference

12 December 2020

2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation

1 reference

12 December 2020

Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil

1 reference

12 December 2020

Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases

1 reference

12 December 2020

Identifiers

DOI

10.1054/BJOC.2000.1166

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference

15 August 2017

1 reference